Hydroxychloroquine
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
An antimalarial drug widely used as a DMARD for the treatment of rheumatoid arthritis and systemic lupus erythematosus (SLE). Hydroxychloroquine is considered one of the safest DMARDs with a favorable side effect profile and is recommended in virtually all SLE patients unless contraindicated. It is often used in combination with methotrexate in RA.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
An antimalarial drug widely used as a DMARD for the treatment of rheumatoid arthritis and systemic lupus erythematosus (SLE). NutriStack rates the supporting evidence as strong. Common adult dosing is 200–400 mg daily (not exceeding 5 mg/kg/day to minimize retinal toxicity) (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: disease modification in rheumatoid arthritis, essential therapy in systemic lupus erythematosus, improved survival in sle patients. 10 sources indexed (2020–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Accumulates in lysosomes and raises intralysosomal pH, inhibiting antigen processing and presentation through MHC class II molecules. This reduces T-cell activation and the downstream inflammatory cascade. Hydroxychloroquine also inhibits Toll-like receptor (TLR7 and TLR9) signaling, reducing type I interferon and pro-inflammatory cytokine production. Additional effects include inhibition of phospholipase A2 and platelet aggregation.
Dosing & protocol.
Take with food or milk to reduce GI side effects; very long tissue half-life means steady state takes months
Full safety detail.
Side effects
- Nausea and GI upset
- Skin rash and hyperpigmentation
- Retinal toxicity (bull's-eye maculopathy with long-term use)
- Headache
- Dizziness
- QT prolongation (rare)
- Myopathy (rare, with long-term use)
- Cardiomyopathy (very rare)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
6- 1Psychiatric Adverse Effects From Hydroxychloroquine Use: A Systematic ReviewPMIDSetty MJ, Kavi RK, Sulthana P et al. · The primary care companion for CNS disorders · 2025
Setty MJ, Kavi RK, Sulthana P et al.. Psychiatric Adverse Effects From Hydroxychloroquine Use: A Systematic Review. The primary care companion for CNS disorders. 2025
- 2Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysisPMIDBerman A, Kenet G, Lubetsky A et al. · RMD open · 2025
Berman A, Kenet G, Lubetsky A et al.. Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis. RMD open. 2025
- 3Hydroxychloroquine-Chloroquine, QT-Prolongation, and Major Adverse Cardiac Events: A Meta-analysis and Scoping ReviewPMIDGarcia MC, Tsang K, Lohit S et al. · The Annals of pharmacotherapy · 2024
Garcia MC, Tsang K, Lohit S et al.. Hydroxychloroquine-Chloroquine, QT-Prolongation, and Major Adverse Cardiac Events: A Meta-analysis and Scoping Review. The Annals of pharmacotherapy. 2024
- 4Efficacy and Safety of Hydroxychloroquine in Patients with IgA Nephropathy: A Meta-AnalysisPMIDZhang Z, Liu X, Ye P et al. · Archivos espanoles de urologia · 2024
Zhang Z, Liu X, Ye P et al.. Efficacy and Safety of Hydroxychloroquine in Patients with IgA Nephropathy: A Meta-Analysis. Archivos espanoles de urologia. 2024
- 5The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic ReviewPMIDFernandes CP, Vernier LS, Dallegrave E et al. · International archives of otorhinolaryngology · 2022
Fernandes CP, Vernier LS, Dallegrave E et al.. The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review. International archives of otorhinolaryngology. 2022
- 6Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic reviewPMIDSharma AN, Mesinkovska NA, Paravar T · Journal of the American Academy of Dermatology · 2020
Sharma AN, Mesinkovska NA, Paravar T. Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review. Journal of the American Academy of Dermatology. 2020
Reference material
4- 7Fraenkel L et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res. 2021.Source linkedPMID
- 8Ruiz-Irastorza G et al. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 2010.Source linkedPMID
- 9Marmor MF et al. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology. 2016.Source linkedPMID
- 10Huo R, Wei C, Yang Y et al.. Hydroxychloroquine: A double‑edged sword (Review). Molecular medicine reports. 2025Source linkedPMID
Common questions.
Quick answers about Hydroxychloroquine, drawn from the data on this page.
What is Hydroxychloroquine?
An antimalarial drug widely used as a DMARD for the treatment of rheumatoid arthritis and systemic lupus erythematosus (SLE). Hydroxychloroquine is considered one of the safest DMARDs with a favorable side effect profile and is recommended in virtually all SLE patients unless contraindicated. It is often used in combination with methotrexate in RA.
What is Hydroxychloroquine used for?
Commonly cited benefits of Hydroxychloroquine include: Disease modification in rheumatoid arthritis; Essential therapy in systemic lupus erythematosus; Improved survival in SLE patients; Favorable safety profile among DMARDs; Lipid-lowering and anti-thrombotic properties. NutriStack rates the overall evidence as strong.
What is a typical dose of Hydroxychloroquine?
A typical adult dose of Hydroxychloroquine is 200–400 mg daily (not exceeding 5 mg/kg/day to minimize retinal toxicity) (as prescribed by your physician). The commonly recommended form is Tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Hydroxychloroquine?
Reported side effects include nausea and gi upset, skin rash and hyperpigmentation, retinal toxicity (bull's-eye maculopathy with long-term use), headache, dizziness, qt prolongation (rare). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Hydroxychloroquine?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Hydroxychloroquine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.